Clinical Trial Update: Omega 3 Fatty Acids and Atrial Fibrillation [NA]

View source ↗

Summary

A clinical trial evaluating omega-3 fatty acids for atrial fibrillation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: University of Dundee | Conditions: Atrial Fibrillation | NA | Status: WITHDRAWN